ITW · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $16.04B | $15.90B | $16.11B | $15.93B | $14.46B | $12.57B | $14.11B | $14.77B |
| Cost of Revenue | $7.56B | $7.60B | $7.94B | $8.14B | $8.49B | $7.38B | $8.19B | $8.60B |
| Research & Development | $302.00M | $292.00M | $284.00M | $269.00M | $239.00M | $214.00M | $221.00M | $233.00M |
| Operating Income | $4.22B | $4.26B | $4.04B | $3.79B | $3.48B | $2.88B | $3.40B | $3.58B |
| Interest Expense | — | — | $266.00M | $203.00M | $202.00M | $206.00M | $221.00M | $257.00M |
| Other Income / (Expense) | $42.00M | $441.00M | $49.00M | $255.00M | $51.00M | $28.00M | $107.00M | $67.00M |
| Income Before Taxes | — | — | $3.82B | $3.84B | $3.33B | $2.70B | $3.29B | $3.39B |
| Provision for Income Taxes | $900.00M | $934.00M | $866.00M | $808.00M | $632.00M | $595.00M | $767.00M | $831.00M |
| Net Income | $3.07B | $3.49B | $2.96B | $3.03B | $2.69B | $2.11B | $2.52B | $2.56B |
| Basic EPS | $10.52 | $11.75 | $9.77 | $9.80 | $8.55 | $6.66 | $7.78 | $7.65 |
| Diluted EPS | $10.49 | $11.71 | $9.74 | $9.77 | $8.51 | $6.63 | $7.74 | $7.60 |
| Basic Shares Outstanding | 291.50M | 296.80M | 302.60M | 309.60M | 315.10M | 316.90M | 323.90M | 335.00M |
| Diluted Shares Outstanding | 292.30M | 297.80M | 303.60M | 310.70M | 316.40M | 318.30M | 325.60M | 337.10M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $11.46 | $11.35 | $11.60 | 5 | ↑2 ↓2 |
| Dec 2027 | $12.42 | $11.94 | $13.01 | 8 | ↑5 ↓1 |
| Dec 2028 | $13.60 | $13.32 | $13.87 | 2 | ↑1 ↓0 |
| Dec 2029 | $14.95 | $14.95 | $14.95 | 1 | ↑1 ↓0 |